In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., also had been resolved. Zepbound is approved to treat obesity and Mounjaro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback